| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,083 |
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 2,083 |
-
|
-
|
-
| | | Operating Expenses | | Research Development | 2,136 | 2,250 | 2,222 | 118 | | Selling General and Administrative | 3,840 | 5,019 | 4,214 | 4,633 | | Non Recurring |
-
|
-
| 2,224 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,892) | (7,269) | (8,660) | (4,751) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 91 | 161 | 287 | 503 | | Earnings Before Interest And Taxes | (3,801) | (7,108) | (8,372) | (4,248) | | Interest Expense | 4 | 5 | 166 |
-
| | Income Before Tax | (3,805) | (7,113) | (8,538) | (4,248) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,805) | (7,113) | (8,538) | (4,248) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,805) | (7,113) | (8,538) | (4,248) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,805) | ($7,113) | ($8,538) | ($4,248) |
|
1.28% Nasdaq 
0.15 (2.30%) 
Income Statement
